Tarsus Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 3.86 M | $242.71 M | 8.54% | 8.89% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.67 M | $230.79 M | 1.85% | 8.45% |
| RTW INVESTMENTS, LP | 08/14/2026 | 3.36 M | $211.29 M | 0.33% | 7.74% |
| JUPITER TOPCO LLC | 08/14/2026 | 2.81 M | $176.83 M | 100.00% | 6.47% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2026 | 2.78 M | $174.70 M | 8.33% | 6.40% |
| MORGAN STANLEY | 08/13/2026 | 1.83 M | $115.00 M | -6.03% | 4.21% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.79 M | $112.86 M | 1.85% | 4.13% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 1.66 M | $104.71 M | -2.83% | 3.83% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2026 | 1.57 M | $98.71 M | 31.94% | 3.61% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 1.43 M | $89.82 M | 152.78% | 3.29% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.19 M | $75.10 M | -0.10% | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 1.11 M | $69.61 M | -1.37% | 2.55% |
| STATE STREET CORP | 09/22/2026 | 1.07 M | $67.53 M | 9.68% | 2.50% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 1.05 M | $66.09 M | 425.00% | 2.42% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 947.50 K | $59.64 M | -25.99% | 2.18% |
| INVESCO LTD. | 08/14/2026 | 785.81 K | $49.46 M | 5.83% | 1.81% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 742.69 K | $46.75 M | 68.94% | 1.71% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 08/14/2026 | 728.64 K | $45.86 M | 0.00% | 1.68% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 710.56 K | $44.72 M | -10.19% | 1.64% |
| FMR LLC | 08/13/2026 | 672.95 K | $42.36 M | -8.23% | 1.55% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 08/14/2026 | 607.27 K | $38.22 M | 21.49% | 1.40% |
| CLEARBRIDGE INVESTMENTS, LLC | 08/13/2026 | 549.39 K | $34.58 M | 0.74% | 1.27% |
| TORONTO DOMINION BANK | 08/14/2026 | 510.25 K | $32.12 M | 0.00% | 1.18% |
| LORD, ABBETT & CO. LLC | 08/14/2026 | 479.27 K | $30.17 M | -43.10% | 1.10% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 08/03/2026 | 427.01 K | $26.88 M | 100.00% | 0.98% |
| CAPTION MANAGEMENT, LLC | 08/14/2026 | 410.00 K | $25.81 M | 105.00% | 0.94% |
| NORTHERN TRUST CORP | 08/13/2026 | 386.61 K | $24.33 M | 9.53% | 0.89% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 385.14 K | $24.24 M | 14.66% | 0.89% |
| LOOMIS SAYLES & CO L P | 08/14/2026 | 380.68 K | $23.96 M | -6.66% | 0.88% |
| TIMESSQUARE CAPITAL MANAGEMENT, LLC | 08/07/2026 | 369.38 K | $23.25 M | -4.94% | 0.85% |
| WASATCH ADVISORS LP | 07/10/2026 | 368.57 K | $23.20 M | 100.00% | 0.85% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 335.83 K | $21.14 M | 2.34% | 0.77% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 335.83 K | $21.14 M | 100.00% | 0.77% |
| TRI LOCUM PARTNERS LP | 08/14/2026 | 328.34 K | $20.67 M | 29.99% | 0.76% |
| MPM BIOIMPACT LLC | 08/14/2026 | 322.01 K | $20.27 M | -2.35% | 0.74% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/14/2026 | 317.58 K | $19.99 M | -65.71% | 0.73% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 295.82 K | $18.62 M | 22.73% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 286.29 K | $18.02 M | 4.97% | 0.66% |
| FRANKLIN TEMPLETON INC | 08/13/2026 | 286.01 K | $18.00 M | -14.29% | 0.66% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 08/13/2026 | 284.90 K | $17.93 M | -7.29% | 0.66% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 277.09 K | $17.44 M | 23.05% | 0.64% |
| ENSIGN PEAK ADVISORS, INC | 08/14/2026 | 268.70 K | $16.91 M | -19.31% | 0.62% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 260.78 K | $16.42 M | -5.10% | 0.60% |
| CITADEL ADVISORS LLC | 09/02/2026 | 241.74 K | $15.21 M | 47.40% | 0.56% |
| BNP PARIBAS FINANCIAL MARKETS | 08/13/2026 | 201.62 K | $12.69 M | -33.57% | 0.46% |
| MACKENZIE FINANCIAL CORP | 08/13/2026 | 191.43 K | $12.05 M | 100.00% | 0.44% |
| JANE STREET GROUP, LLC | 08/14/2026 | 190.10 K | $11.96 M | -0.99% | 0.44% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 188.50 K | $11.86 M | 444.80% | 0.43% |
| PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2026 | 150.00 K | $9.44 M | 100.00% | 0.35% |
| JPMORGAN CHASE & CO | 08/12/2026 | 139.98 K | $8.68 M | 359.29% | 0.32% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Tarsus Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 334 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals Inc. The most heavily invested institutionals were:
Assenagon Asset Management S.A.: 615,974
WASATCH ADVISORS LP: 468,041
TimesSquare Capital Management, LLC: 324,765
Allspring Global Investments Holdings, LLC: 151,606
COMMONWEALTH EQUITY SERVICES, LLC: 70,917
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC: 67,048
109.83% of Tarsus Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 59.07 M shares in the last 24 months. This purchase volume represents approximately $4.40 B in transactions.